Abbisko Therapeutics Co, Ltd

This early-phase study tests a new oral drug, ABSK121-NX, in adults with advanced solid tumors that have stopped responding to standard treatments. The main goal is to check the drug's safety and find the right dose. About 169 participants will take the drug in 28-day cycles, and…

This study tests a new drug called ABSK021 (Pimicatinib) for people with tenosynovial giant cell tumor (TGCT), a rare but painful tumor that grows in and around joints. About 94 adults with tumors that cannot be removed by surgery will take either the drug or a placebo for 24 wee…

This study tests a new drug (ABSK-011) combined with atezolizumab or standard treatments in about 118 adults with advanced liver cancer that cannot be removed by surgery. The goal is to see if the combination is safe and can shrink tumors, especially in patients whose cancers hav…